Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals

被引：0

作者：

Cabibbo, G. ^{[1
]}

Cacciola, I. ^{[2
]}

Cannavo, M. R. ^{[3
]}

Madonia, S. ^{[4
]}

Calvaruso, V. ^{[5
]}

Petta, S. ^{[1
]}

Di Stefano, M. ^{[6
]}

Larocca, L. ^{[7
]}

Prestileo, T. ^{[8
]}

Tine, F. ^{[9
]}

Digiacomo, A. ^{[10
]}

Bertino, G. ^{[11
]}

Giannitrapani, L. ^{[12
]}

Benanti, F. ^{[13
]}

Davi, A. ^{[14
]}

Volpes, R. ^{[15
]}

Guarneri, L. ^{[16
]}

Averna, A. ^{[17
]}

Scalisi, I. ^{[18
]}

Iacobello, C. ^{[19
]}

Mazzola, G. ^{[20
]}

Cartabellotta, F. ^{[21
]}

Portelli, V. ^{[22
]}

Russello, M. ^{[23
]}

Scifo, G. ^{[24
]}

Squadrito, G. ^{[25
]}

Raimondo, G. ^{[25
]}

Craxi, A. ^{[1
]}

Di Marco, V. ^{[1
]}

Camma, C. ^{[1
]}

机构：

[1] Univ Palermo, Gastroenterol & Epatol, DIBIMIS, Palermo, Italy

[2] AOUP G Di Martino, Epatol Clin & Mol, Messina, Italy

[3] ARNAS Garibaldi Nesima, UOD Epatol, Catania, Italy

[4] AO Cervello Villa Sofia, Med Interna, Palermo, Italy

[5] Univ Palermo, Gastroenterol & Epatol, Palermo, Italy

[6] UmbertoIO, Malattie Infett, Siracusa, Italy

[7] AOUP Vittorio Emanuele, Malattie INfett, Catania, Italy

[8] ARNAS Civ Di Cristina Benefratelli, Malattie Infett, Palermo, Italy

[9] AO Cervello Villa Sofia, Gastroenterol, Palermo, Italy

[10] Presidio Osped, Med Interna, Comiso, Italy

[11] Vittorio Emanuele, Med Interna & Urgenza, Catania, Italy

[12] Univ Palermo, Med Interna, Palermo, Italy

[13] Garibaldi Nesima, Malattie Infett, Catania, Italy

[14] Presidio Osped Modica, Malattie Infett, Modica, Italy

[15] ISMETT, Palermo, Italy

[16] Umberto I, Malattie Infett, Enna, Italy

[17] S Elia, Malattie Infett, Caltanissetta, Italy

[18] Presidio Osped Castelvetrano, Med Interna, Trapani, Italy

[19] Cannizzaro, Malattie Infett, Catania, Italy

[20] Univ Palermo, Malattie Infett, Palermo, Italy

[21] Buccheri La Ferla, Med Interna, Palermo, Israel

[22] PO, Malattie Infett, Trapani, Israel

[23] Garibaldi, Gastroenterol, Catania, Italy

[24] Umberto I, Malattie Infett, Siracusa, Italy

[25] Univ Messina, Epatol Clin & Mol, Messina, Italy

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期

关键词：

D O I：

10.1016/S0168-8278(17)30734-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-096

引用

页码：S218 / S218

页数：1

共 50 条

[1] Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)
Cabibbo, G.
Cacciola, I.
Cannavo, M. R.
Madonia, S.
Calvaruso, V.
Petta, S.
Distefano, M.
Larocca, L.
Prestileo, T.
Tine, F.
Digiacomo, A.
Bertino, G.
Giannitrapani, L.
Benanti, F.
Davi, A.
Volpes, R.
Scalisi, I.
Iacobello, C.
Mazzola, G.
Cartabellotta, F.
Guarneri, L.
Portelli, V.
Averna, A.
Russello, M.
Scifo, G.
Squadrito, G.
Raimondo, G.
Craxi, A.
Di Marco, V.
Camma, C.
DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E59 - E59
[2] Increased incidence or recurrence of hepatocellular carcinoma in hepatitis C virus cirrhotic patients treated with direct-acting antivirals: myth or fact?
Maida, Marcello
Cabibbo, Giuseppe
Camma, Calogero
EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (04) : 307 - 309
[3] Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals
Kishta, Sara
Tabll, Ashraf
Kolaric, Tea Omanovic
Smolic, Robert
Smolic, Martina
BIOMEDICINES, 2020, 8 (06) : 1 - 15
[4] Hepatocellular Carcinoma Occurrence and Recurrence in Hepatitis C-infected Patients Treated with Direct-acting Antivirals
Syed, Taseen
Fazili, Javid
Ali, Ijlal Akbar
Zhao, Daniel
Hughes, Diane
Mahmood, Sultan
CUREUS, 2018, 10 (06):
[5] Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals
Lleo, Ana
Aglitti, Andrea
Aghemo, Alessio
Maisonneuve, Patrick
Brunoa, Savino
Persico, Marcello
Rendina, Maria
Ciancio, Alessia
Lampertico, Pietro
Brunetto, Maurizia R.
Di Marco, Vito
Zuin, Massimo
Andreone, Pietro
Villa, Erica
Troshina, Giulia
Degasperi, Elisabetta
Coco, Barbara
Calvaruso, Vincenza
Giorgini, Alessia M.
Conti, Fabio
Di Leo, Alfredo
Marzi, Uca
Boccaccio, Vincenzo
Bollani, Simona
Colombo, Massimo
Marzi, Luca
DIGESTIVE AND LIVER DISEASE, 2019, 51 (02) : 310 - 317
[6] DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS
Buonfiglioli, F.
Conti, F.
Andreone, P.
Crespi, C.
Foschi, F. G.
Lenzi, M.
Mazzella, G.
Verucchi, G.
Brillanti, S.
JOURNAL OF HEPATOLOGY, 2016, 64 : S215 - S215
[7] Direct acting antivirals for hepatitis c and hepatocellular carcinoma recurrence: an unsolved mystery
Dines, Virginia A.
Leise, Michael D.
TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1493 - S1495
[8] Risk of hepatocellular carcinoma recurrence in patients treated with direct acting antivirals in real world setting
Dybowska, D.
Pazgan-Simon, M.
Flisiak, R.
Socha, L.
Wawrzynowicz-Syczewska, M.
Janczewska, E.
Lorenc, B.
Tronina, O.
Tudrujek, M.
Tomasiewicz, K.
Sitko, M.
Garlicki, A.
Zarebska-Michaluk, D.
Orlowska, I.
Simon, K.
Halota, W.
Berak, H.
Horban, A.
Mazur, W.
Czauz-Andrzejuk, A.
Citko, J.
Jaroszewicz, J.
Bialkowska, J.
Jablkowski, M.
Bielica-Wdowik, T.
Baka-Cwierz, B.
Laurans, L.
Deron, Z.
Pawlowska, M.
JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 65 - 65
[9] Evolution Of Cirrhotic Patients With Hepatitis C Virus Treated With Direct Acting Antivirals
Murcia, Oscar
Carnicer, Fernando
Gomez-Escolar, Laura
Miralles, Cayetano
Grino, Maria Pilar
Barquero Martin, Claudia
Pascual, Sonia
HEPATOLOGY, 2017, 66 : 768A - 768A
[10] Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
Leal, Cassia
Strogoff-de-Matos, Jorge
Theodoro, Carmem
Teixeira, Rosangela
Perez, Renata
Guarana, Thais
Pinto, Paulo de Tarso
Guimaraes, Tatiana
Artimos, Solange
VIRUSES-BASEL, 2023, 15 (01):

← 1 2 3 4 5 →